Publications

5530 Results

Cloning and characterization of the (15;17) translocation break point region in acute promyelocytic leukemia.

Authors
RS Lemons;D Eilender;R Waldmann;M Rebentisch;A Frej;D Ledbetter;C Willman;T McConnell;P O'Connell
Journal / Conference
Genes Chromosomes and Cancer 2:79-87
Year
1990
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600, SWOG-8750

A phase II study of intravenous 6-thioguanine (NSC-752) in multiple myeloma: A Southwest Oncology Group study.

Authors
MB Edelstein;JJ Crowley;FA Valeriote;JD Bonnet;JO Carden;RC Khanna;SE Salmon;JS Ungerleider
Journal / Conference
IND 8:S83-S86
Year
1990
Research Committee(s)
Myeloma
Study Number(s)
SWOG-8604

Treatment of small cell lung cancer with an alternating chemotherapy regimen given at weekly intervals. A Southwest Oncology Group study.

Authors
CW Taylor;J Crowley;SK Williamson;TP Miller;SA Taylor;PG Giri;RL Stephens;RB Livingston
Journal / Conference
JCO 8(11):1811-1817
Year
1990
Research Committee(s)
Lung
Study Number(s)
SWOG-8606

Phase II trial of high dose intermittent interleukin-2 in metastatic renal cell carcinoma: A Southwest Oncology Group study.

Authors
RM Bukowski;P Goodman;ED Crawford;JS Sergi;BG Redman;RP Whitehead
Journal / Conference
JNCI 82(3):143-146
Year
1990
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8617

Phase II evaluation of recombinant gamma interferon (r-GIFN) in patients with advanced pancreatic carcinoma: A Southwest Oncology Group study.

Authors
DD Von Hoff;T Fleming;JS Macdonald;PJ Goodman;J Van Damme;TD Brown;T O'Rourke;LG Feun;MD Keppen
Journal / Conference
JBRM 9:584-587
Year
1990
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8626

Phase II study of continuous infusion recombinant gamma interferon in renal carcinoma: A Southwest Oncology Group study.

Authors
JP Kuebler;PJ Goodman;TD Brown;ED Crawford;CL Reitz;WA Knight III;JA Kish
Journal / Conference
IND 8:307-309
Year
1990
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8707

A phase II trial of recombinant tumor necrosis factor in patients with metastatic colorectal adenocarcinoma. A Southwest Oncology Group study.

Authors
RP Whitehead;T Fleming;JS Macdonald;PJ Goodman;J Neefe;TJ Braun;LJ Swinnen;EM Hersh
Journal / Conference
JBRM 9:588-591
Year
1990
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8743

Determinants of improved outcome in small cell lung cancer: An analysis of 2,580-patient Southwest Oncology Group data base.

Authors
KS Albain;JJ Crowley;M LeBlanc;RB Livingston
Journal / Conference
JCO 8(9):1563-1574
Year
1990
Research Committee(s)
Lung
Study Number(s)
SWOG-7628, SWOG-7828, SWOG-7924, SWOG-8122, SWOG-8232, SWOG-8269, SWOG-8573, SWOG-8606

Immunobiologic factors predictive of clinical outcome in diffuse large-cell lymphoma.

Authors
DJ Slymen;TP Miller;SM Lippman;CM Spier;DP Kerrigan;JA Rybski;CS Rangel;LC Richter;TM Grogan
Journal / Conference
JCO 8:986-993
Year
1990
Research Committee(s)
Lymphoma

Clinical applications of cellular DNA content parameters determined by flow cytometry in squamous cell cancers of the head and neck.

Authors
JF Ensley;Z Maciorowski;H Pietraszkiewicz;F deBraud;W Sakr;J Kish;M Al-Sarraf;E Tapazoglou
Journal / Conference
Adjuvant Therapy of Cancer IV:101-108
Year
1990
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8855